Skip to content

EBITDA at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$5.51M-8.0%
Eli Lilly logo
Eli LillyLLY
Apple logo
AppleAAPL
Amazon logo
AmazonAMZN
AbbVie logo
AbbVieABBV
Alphabet Inc. logo
Alphabet Inc.GOOGL

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+81.6%
Enterprise value$76.31M+90.2%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Calculated from electroCore, Inc.’s reported figures.

$5.3Mebit+
$21.0KDepreciation Depletion & Amortization
=-$5.3M

The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s EBITDA?
electroCore, Inc. (ECOR) reported EBITDA of -$5.3M in Q1 2026.
How has electroCore, Inc.'s EBITDA changed year-over-year?
electroCore, Inc.'s EBITDA decreased by 44.4% year-over-year, from -$3.67M to -$5.3M.
What is the long-term trend for electroCore, Inc.'s EBITDA?
Over 3 years (2021 to 2024), electroCore, Inc.'s EBITDA has grown at a -16.6% compound annual growth rate (CAGR), from -$19.66M to -$11.4M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.